HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aspen Chun Selected Research

VU0652957

3/2019Discovery of VU2957 (Valiglurax): An mGlu4 Positive Allosteric Modulator Evaluated as a Preclinical Candidate for the Treatment of Parkinson's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Aspen Chun Research Topics

Disease

1Parkinson Disease (Parkinson's Disease)
03/2019
1Schizophrenia (Dementia Praecox)
10/2013

Drug/Important Bio-Agent (IBA)

1VU0652957IBA
03/2019
1Metabotropic Glutamate 5 ReceptorIBA
10/2013